AnaptysBio, Inc. (ANAB)
$46.67+2.37%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.0B
- Beta
- 0.41
- P/E (TTM)
- 6.91
- Short % float
- 13.00%
- Days to cover
- 8.2
- SI change
- -3.7%
- 1W
- +2.23%
- 1M
- -14.65%
- vs SPY 1W
- +3.21%
- vs SPY 1M
- -16.51%
Industry peers
FMP comparable companies · ranked by market cap
- IMVTSELLImmunovant, Inc.$6.3BCRISISQ 25$30.47-2.82%
- DNTHSELLDianthus Therapeutics, Inc.$4.6BCRISISQ 1$82.37-3.63%
- XNCRSELLXencor, Inc.$1.8BRECOVERYQ 15$24.63-0.55%
- ODTXSELLOdyssey Therapeutics, Inc.$913MQ 12$19.00-3.71%
- MLTXSELLMoonLake Immunotherapeutics$910MCRISISQ -1$10.82-2.59%
- ANNXSELLAnnexon, Inc.$659MCRISISQ -9$4.02-4.18%
- ACRSSELLAclaris Therapeutics, Inc.$535MCRISISQ 9$3.83-2.59%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 28
- VALUE
- 10
- GROWTH
- 55
- GARP
- 46
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA61.7%
GROSS133
OP56
NET82
[VALUATION]
P/E TTM6.91
P/E FWD7.83
SECTOR PE20.48
INDUSTRY PE13.99
P/B129.03
P/FCF-
EV/EBITDA16.51
EV/EBIT-
PEG1.14
FCF YIELD-
RISK
INT COV-
D/E2546.89
ALTMAN Z-
CURR RATIO5.61
ND/EBITDA-
BETA0.41
Company news
FAQ
- What is LOPJLB’s current signal on ANAB?
- LOPJLB’s latest quantitative signal on AnaptysBio, Inc. (ANAB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ANAB in?
- AnaptysBio, Inc. (ANAB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does AnaptysBio, Inc. (ANAB) do?
- AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The companyâs products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b t…